Alliancebernstein L.P. boosted its position in Masimo Corporation (NASDAQ:MASI) by 9.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 139,921 shares of the medical equipment provider’s stock after acquiring an additional 12,660 shares during the period. Alliancebernstein L.P. owned 0.27% of Masimo Corporation worth $12,758,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Prudential Financial Inc. boosted its holdings in Masimo Corporation by 14.4% in the second quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock worth $50,442,000 after acquiring an additional 69,810 shares in the last quarter. American Century Companies Inc. boosted its holdings in Masimo Corporation by 98.0% in the second quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock worth $19,100,000 after acquiring an additional 103,656 shares in the last quarter. D L Carlson Investment Group Inc. boosted its holdings in Masimo Corporation by 32.4% in the second quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock worth $4,216,000 after acquiring an additional 11,315 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its holdings in Masimo Corporation by 27.1% in the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock worth $99,872,000 after acquiring an additional 233,412 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock worth $42,466,000 after acquiring an additional 45,833 shares in the last quarter. Institutional investors and hedge funds own 83.21% of the company’s stock.

In other news, COO Anand Sampath sold 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $92.00, for a total value of $3,680,000.00. Following the sale, the chief operating officer now directly owns 20,000 shares of the company’s stock, valued at approximately $1,840,000. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Sanford Fitch sold 11,000 shares of the business’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total value of $959,750.00. Following the completion of the sale, the director now directly owns 72,249 shares in the company, valued at $6,303,725.25. The disclosure for this sale can be found here. Over the last three months, insiders sold 126,000 shares of company stock worth $11,732,930. Insiders own 16.60% of the company’s stock.

Shares of Masimo Corporation (NASDAQ MASI) opened at 84.98 on Monday. The stock has a market capitalization of $4.41 billion, a P/E ratio of 13.93 and a beta of 0.84. Masimo Corporation has a 52 week low of $53.78 and a 52 week high of $104.71. The stock has a 50 day moving average price of $85.78 and a 200 day moving average price of $90.95.

Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The firm had revenue of $192.90 million for the quarter, compared to analysts’ expectations of $189.03 million. During the same period in the previous year, the firm posted $0.57 EPS. The business’s revenue for the quarter was up 11.8% compared to the same quarter last year. On average, equities research analysts expect that Masimo Corporation will post $2.80 EPS for the current year.

Several brokerages have issued reports on MASI. BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a report on Monday, August 14th. BidaskClub lowered Masimo Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price target (up previously from $105.00) on shares of Masimo Corporation in a report on Thursday, August 3rd. Roth Capital increased their price target on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Finally, Zacks Investment Research upgraded Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $95.00.

WARNING: This piece of content was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/25/alliancebernstein-l-p-purchases-12660-shares-of-masimo-corporation-masi.html.

Masimo Corporation Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.